Alpha Adducin (ADD1) Gene Polymorphism and New Onset of Diabetes Under the Influence of Selective Antihypertensive Therapy in Essential Hypertension

Author(s): Sumeet Gupta*, Vikas Jhawat, Bimal Kumar Agarwal, Partha Roy, Vipin Saini.

Journal Name: Current Hypertension Reviews

Volume 15 , Issue 2 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Different antihypertensive therapies (especially diuretics) are reported to induce the new onset of diabetes in some hypertensive patients. α-adducin-1 (ADD1) gene is salt sensitive gene which has its role in etiology of hypertension via salt sensitivity. Therefore, the G460T polymorphism of ADD1 gene may be associated with new onset of diabetes under the influence of diuretic and other antihypertensive therapies.

Aim: To assess the correlation between genetic polymorphism (ADD1 G460T polymorphism) and glycaemic disturbance under influence of diuretic and other antihypertensive drug therapies.

Materials and Methods: We recruited study subjects, 270 normotensive as control (150 male and 120 females), 270 hypertensive patients (95 male and 175 females) and 240 hypertensive with new onset of diabetes patients (80 male and 160 females). All study samples were genotyped for ADD1 polymorphic alleles and analyzed the relationship between different genotypes with respect to anthropometric and clinical parameters along with drug therapies.

Results: Clinical and anthropometric parameters (such as age, SBP, DBP, FBG, height, weight, WC, HP, W/H ratio, and BMI) of study population were found highly statistically significant (p<0.05) at base value. Further, genotype wise comparison of all the above parameters revealed most of them as non-significant (p>0.05). Whereas, comparison between genotype and different antihypertensive drug therapy of hypertensive patients, specifically, diuretic therapy as mono in male (p=0.0227) and female (p=0.0292) and in combination with BBs in both male (p=0.0023) and female (p=0.0079) revealed a higher FBG level in variant T allele. In case of hypertensive with new onset of diabetes patients, only female population showed a slightly statistically significant (p=0.0413) difference in FBG level with diuretic mono therapy. Other antihypertensive drug therapies were safe and effective either as mono or in combination therapy.

Discussion: Anthropometric parameters may be the indicative factors for hypertension and diabetes. Variant T allele of ADD1 gene may be considered as the risk factor for the development of diabetes in hypertensive patients. Diuretics as mono therapy and in combination with BBs may be considered as the risk factor for new onset of diabetes in EH patients carrying variant T allele (either as TG or TT).

Keywords: Hypertension, antihypertensive therapy, diuretics, new onset of diabetes alpha adducing gene (ADD1), gene polymorphism, pharmacogenomics.

[1]
Mohan V, Seedat YK, Pradeepa R. The rising burden of diabetes and hypertension in southeast Asian and African regions: Need for effective strategies for prevention and control in primary health care settings. Int J Hypertens 2013; 2013: 409083.
[2]
Swami SS, Swami SC, Patil VW, Kanhere AM. Hypertension and diabetes in India: A review. Int J Clin Biochem Res 2015; 2: 54-8.
[3]
Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation 2016; 134: 441-50.
[4]
World Health Organization. A global brief on hypertension. World Health Day 2013; pp. 1-39.
[5]
James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-20.
[6]
Verdecchia P, Reboldi G, Angeli F, et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 2004; 43: 963-9.
[7]
Carter BL, Einhorn PT, Brands M, et al. Thiazide induced dysglycemia: Call for research from a working group from the national heart, lung, and blood institute. Hypertension 2008; 52: 30-6.
[8]
Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: A network meta-analysis. Lancet 2007; 369: 201-7.
[9]
Helgeland A, Leren P, Foss OP, Hjermann I, Holme I, Lund-Larsen PG. Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study. Am J Med 1984; 76: 802-5.
[10]
Mykkanen L, Kuusisto J, Pyorala K, Laakso M, Haffner SM. Increased risk of non-insulin-dependent diabetes mellitus in elderly hypertensive subjects. J Hypertens 1994; 12: 1425-2.
[11]
Karagiannis A, Tziomalos K, Pagourelias ED, Gossios TD, Athyros VG. Effect of antihypertensive drug-associated diabetes on cardiovascular risk. Hellenic J Cardiol 2010; 51: 195-9.
[12]
Gurwitz JH, Bohn RL, Bohn RL, et al. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med 1992; 118: 273-8.
[13]
Blackburn DF, Wilson TW. Antihypertensive medications and blood sugar: Theories and implications. Can J Cardiol 2006; 22: 229-3.
[14]
Dunder K, Lind L, Zethelius B, Berglund L, Lithell H. Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: Population based cohort study. BMJ 2003; 326: 681.
[15]
Hughes CA, Bennett V. Adducin: A physical model with implications for function in assembly of spectrin-actin complexes. J Biochem 1995; 270: 18990-6.
[16]
Ramu P, Umamaheswaran G, Shewade DG, Swaminathan RP, Balachander J, Adithan C. Gly460Trp polymorphism of the ADD1 gene and essential hypertension in an Indian population: A meta-analysis on hypertension risk. Indian J Hum Genet 2010; 16: 8-15.
[17]
Manunta P, Cusi D, Barlassina C, et al. Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients. Kidney Int 1998; 53: 1471-8.
[18]
Gorden P. Glucose intolerance with hypokalemia: Failure of short-term potassium depletion in normal subjects to reproduce the glucose and insulin abnormalities of clinical hypokalemia. Diabetes 1973; 22: 544-51.
[19]
Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide diuretics, potassium, and the development of diabetes: A quantitative review. Hypertension 2006; 48: 219-4.
[20]
Cusi D, Barlassina C, Azzani T, et al. Adducin polymorphism in primary hypertension: Linkage and association study; relationship to salt sensitivity. Lancet 1997; 349: 1353-7.
[21]
Cooper ME, Rumble JR, Allen TJ, O’brien RC, Jerums G, Doyle AE. Antihypertensive therapy in a model combining spontaneous hypertension with diabetes. Kidney Int 1992; 4: 898-3.
[22]
Bozkart O. Pharmacogenetics of antihypertensive drugs and risk of diabetes. Thesis Utrecht University, chapter 2.1, page 19-31, 2007.
[23]
Gupta S, Chattopadhyaya I, Agrawal BK, Sehajpal PK, Goel RK. Correlation of Renin Angiotensin System (RAS) candidate gene polymorphisms with response to Ramipril in patients with essential hypertension. J Postgrad Med 2015; 61: 21-6.
[24]
Gupta S, Agrawal KB, Goel KR, Sehajpal KP. Angiotensin-converting enzyme gene polymorphism in hypertensive rural population of Haryana, India. J Emerg Trauma Shock 2009; 2: 150-4.
[25]
Miller SA, Dykes DD, Polesky HF. A simple salting procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
[26]
Shin MH, Chung EK, Kim HN, et al. Alphaadducin Gly460Trp polymorphism and essential hypertension in Korea. J Korean Med Sci 2004; 19: 812-4.
[27]
Gupta S, Agrawal BK, Sehajpal PK, Goel RK. Prevalence and predictors of essential hypertension in the rural population of haryana, India: An hospital based study. J Rural Trop Public Health 2011; 10: 29-4.
[28]
Gupta V, Singla R, Bedi M. Correlation of anthropometric parameters with blood pressure: an anthropometric study in North Indian Haryanvi males. Int J Anat Res 2016; 4: 2485-9.
[29]
Ranade K, Hsuing AC, Wu KD, et al. Lack of evidence for an association between alpha adducing and blood pressure regulation in Asian population. Am J Hyper 2000; 13: 704-9.
[30]
Manunta P, Burnier M, D’Amico M, et al. Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. Hypertension 1999; 33: 694-7.
[31]
Ferrandi M, Salardi S, Tripodi G, et al. Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: relation to genetic hypertension. Am J Physiol 1999; 277: H1338-9.
[32]
Plavinik FL, Rodrigues CIS, Zanella MT, Ribeiro AB. Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy. Hypertension 1992; 19(Suppl. II): II-26-II-2.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 2
Year: 2019
Page: [123 - 134]
Pages: 12
DOI: 10.2174/1573402114666180731111453
Price: $58

Article Metrics

PDF: 68
HTML: 4